|
1
|
Despres JP and Lemieux I: Abdominal
obesity and metabolic syndrome. Nature. 444:881–887. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ko SC, Lee M, Lee JH, Lee SH, Lim Y and
Jeon YJ: Dieckol, a phlorotannin isolated from a brown seaweed,
Ecklonia cava, inhibits adipogenesis through AMP-activated protein
kinase (AMPK) activation in 3T3-L1 preadipocytes. Environ Toxicol
Pharmacol. 36:1253–1260. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
White UA and Stephens JM: Transcriptional
factors that promote formation of white adipose tissue. Mol Cell
Endocrinol. 318:10–14. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rosen ED and Spiegelman BM: PPARgamma: A
nuclear regulator of metabolism, differentiation, and cell growth.
J Biol Chem. 276:37731–37734. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu Z, Rosen ED, Brun R, Hauser S, Adelmant
G, Troy AE, McKeon C, Darlington GJ and Spiegelman BM:
Cross-regulation of C/EBP alpha and PPAR gamma controls the
transcriptional pathway of adipogenesis and insulin sensitivity.
Mol Cell. 3:151–158. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee JH, Kim T, Lee JJ, Lee KJ, Kim HK, Yun
B, Jeon J, Kim SK and Ma JY: The herbal medicine KBH-1 inhibits fat
accumulation in 3T3-L1 adipocytes and reduces high fat diet-induced
obesity through regulation of the AMPK pathway. PLoS One.
10:e01420412015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lin JT, Chen HM, Chiu CH and Liang YJ:
AMP-activated protein kinase activators in diabetic ulcers: From
animal studies to phase II drugs under investigation. Expert Opin
Investig Drugs. 23:1253–1265. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim SK and Kong CS: Anti-adipogenic effect
of dioxinodehydroeckol via AMPK activation in 3T3-L1 adipocytes.
Chem Biol Interact. 186:24–29. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ceddia RB: The role of AMP-activated
protein kinase in regulating white adipose tissue metabolism. Mol
Cell Endocrinol. 366:194–203. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hotta K, Funahashi T, Arita Y, Takahashi
M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K,
et al: Plasma concentrations of a novel, adipose-specific protein,
adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc
Biol. 20:1595–1599. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yamauchi T, Kamon J, Waki H, Terauchi Y,
Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N,
et al: The fat-derived hormone adiponectin reverses insulin
resistance associated with both lipoatrophy and obesity. Nat Med.
7:941–946. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Okada-Iwabu M, Yamauchi T, Iwabu M, Honma
T, Hamagami K, Matsuda K, Yamaguchi M, Tanabe H, Kimura-Someya T,
Shirouzu M, et al: A small-molecule AdipoR agonist for type 2
diabetes and short life in obesity. Nature. 503:493–499. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Holland WL and Scherer PE: Cell Biology.
Ronning after the adiponectin receptors. Science. 342:1460–1461.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lazra Y, Falach A, Frenkel L, Rozenberg K,
Sampson S and Rosenzweig T: Autocrine/paracrine function of
globular adiponectin: Inhibition of lipid metabolism and
inflammatory response in 3T3-L1 adipocytes. J Cell Biochem.
116:754–766. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Poudel B, Nepali S, Xin M, Ki HH, Kim YH,
Kim DK and Lee YM: Flavonoids from Triticum aestivum inhibit
adipogenesis in 3T3-L1 cells by upregulating the insig pathway. Mol
Med Rep. 12:3139–3145. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cantó C, Gerhart-Hines Z, Feige JN,
Lagouge M, Noriega L, Milne JC, Elliott PJ, Puigserver P and Auwerx
J: AMPK regulates energy expenditure by modulating NAD+
metabolism and SIRT1 activity. Nature. 458:1056–1060. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liou CJ, Lai XY, Chen YL, Wang CL, Wei CH
and Huang WC: Ginkgolide C suppresses adipogenesis in 3T3-L1
adipocytes via the AMPK signaling pathway. Evid Based Complement
Alternat Med. 2015:2986352015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee YK, Lee WS, Hwang JT, Kwon DY, Surh YJ
and Park OJ: Curcumin exerts antidifferentiation effect through
AMPKalpha-PPAR-gamma in 3T3-L1 adipocytes and antiproliferatory
effect through AMPKalpha-COX-2 in cancer cells. J Agric Food Chem.
57:305–310. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ahn J, Lee H, Kim S, Park J and Ha T: The
anti-obesity effect of quercetin is mediated by the AMPK and MAPK
signaling pathways. Biochem Biophys Res Commun. 373:545–549. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen S, Li Z, Li W, Shan Z and Zhu W:
Resveratrol inhibits cell differentiation in 3T3-L1 adipocytes via
activation of AMPK. Can J Physiol Pharmacol. 89:793–799.
2011.PubMed/NCBI
|
|
22
|
Daval M, Foufelle F and Ferré P: Functions
of AMP-activated protein kinase in adipose tissue. J Physiol.
574:55–62. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Giri S, Rattan R, Haq E, Khan M, Yasmin R,
Won JS, Key L, Singh AK and Singh I: AICAR inhibits adipocyte
differentiation in 3T3L1 and restores metabolic alterations in
diet-induced obesity mice model. Nutr Metab (Lond). 3:312006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Habinowski SA and Witters LA: The effects
of AICAR on adipocyte differentiation of 3T3-L1 cells. Biochem
Biophys Res Commun. 286:852–856. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee H, Kang R, Bae S and Yoon Y: AICAR, an
activator of AMPK, inhibits adipogenesis via the WNT/β-catenin
pathway in 3T3-L1 adipocytes. Int J Mol Med. 28:65–71.
2011.PubMed/NCBI
|
